Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Priorix-Tetra and Varilrix in Healthy Children
NCT00226499Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 10
01
Overview
A Phase 3 trial of GSK208136, varicella virus vaccine live in varicella (VZV), sponsored by GSK. Started Sep 2005; status: completed.
02
Drugs
GSK208136varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00226499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226499.